Current state and prospects of nano-delivery systems for sorafenib. Issue 18 (12th December 2018)

• Record Type: Journal Article
• Authors: Khan, Muhammad Adeeb; Raza, Abida; Ovais, Muhammad; Sohail, Muhammad Farhan; Ali, Shaukat
• Is Part Of: International journal of polymeric materials. Volume 67:Issue 18(2018)
• Page Start: 1105
• Page End: 1115
• Publication Date: 2018-12-12
• Subjects: Hepatocellular carcinoma improved bioavailability -- nanoparticles -- sorafenib; Polymers -- Periodicals; Plastics -- Periodicals; 620.19205
• DOI: 10.1080/00914037.2018.1429434
• Languages: English
• ISSNs: 0091-4037

Abstract

ABSTRACT: Sorafenib is the only approved targeted agent against hepatocellular carcinoma (HCC). It has several limitations predominantly poor aqueous solubility and hepatic first-pass effect that limits its oral delivery leading to low bioavailability, large inter-subject variability, narrow therapeutic window and side effects. Tosylate is used to improve its solubility, which is practically insoluble in water (60 µg/mL) so problems with sorafenib solubility persist. To improve the paharmacokinetic profile, minimize the side effects, and targeting drug to the tumor tissues, several polymeric nano-formulations are being evaluated. In this comprehensive review, various reported polymeric nano-delivery systems for sorafenib are comprehensively covered. GRAPHICAL ABSTRACT: